Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Masitinib in Symptomatic Mild to Moderate COVID-19
NCT05047783Phase 2Unknown
- Sponsor
- AB Science
- Start
- Nov 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of masitinib in coronavirus disease 2019 (COVID-19), sponsored by AB Science. Status: unknown.
02
Drugs
masitinib
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05047783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05047783.